Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Mar 14, 2018 · 10-K · 73 days after period end · 0001171843-18-001934
| Metric | Q4 2017 | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Net Income | -$5.55M | -$6.96M | -$6.34M | $7.23M |
| EPS Diluted | -$0.33 | -$0.42 | -$0.38 | $0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 14, 2018 · 73 d after period end
